Sign in

CIK 0001001233

  • Non-accelerated filer
  • Smaller reporting company

SANGAMO THERAPEUTICS, INC

Sign in to watch
Ticker
SGMOQ
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680359556
Phone
+1 510-970-6000
Business address
501 CANAL BLVD., RICHMOND, CA, 94084
Former names
SANGAMO BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-24 Dubois-Stringfellow Nathalie SVP-Chief Development Officer Grant or award · Stock Option (Right to Buy) +249,375 249,375
2023-02-24 Fontenot Jason D. SVP, Chief Scientific Officer Grant or award +42,750 145,917
2023-02-24 Fontenot Jason D. SVP, Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +199,500 199,500
2023-02-24 Duraibabu Prathyusha SVP, Chief Financial Officer Grant or award +53,438 140,755
2023-02-24 Duraibabu Prathyusha SVP, Chief Financial Officer Grant or award · Stock Option (Right to Buy) +249,375 249,375
2023-02-24 Macrae Sandy President, CEO and Director Grant or award +157,300 678,476
2023-02-24 Macrae Sandy President, CEO and Director Grant or award · Stock Option (Right to Buy) +734,050 734,050
2022-12-15 Horn Margaret A Director Grant or award +18,750 18,750
2022-12-15 Horn Margaret A Director Grant or award · Stock Option (Right to Buy) +37,500 37,500
2022-12-15 Beers Courtney Director Grant or award +18,750 18,750
2022-12-15 Beers Courtney Director Grant or award · Stock Option (Right to Buy) +37,500 37,500
2022-08-30 BIOGEN INC. 10% owner Sale −100,000 $5.27 $527K 23,652,466
2022-08-29 BIOGEN INC. 10% owner Sale −400,000 $5.33 $2.1M 23,752,466
2022-08-13 Willoughby Scott B. SVP, Gen. Counsel & Secretary Shares withheld for taxes −864 $6.33 $5K 92,966
2022-06-25 McClung David Mark EVP, Chief Operating Officer Shares withheld for taxes −11,525 $4.31 $50K 175,816
2022-06-11 Duraibabu Prathyusha SVP, Chief Financial Officer Shares withheld for taxes −864 $3.76 $3K 86,595
2022-06-11 Duraibabu Prathyusha Vice President, Finance Shares withheld for taxes −842 $3.76 $3K 86,617
2022-06-03 Markels John Director Purchase +6,784 $3.69 $25K 32,484
2022-06-01 PARKER H STEWART Director Purchase +5,000 $3.60 $18K 48,700
2022-04-29 Willoughby Scott B. SVP, Gen. Counsel & Secretary Shares withheld for taxes −140 $4.15 $581 90,709

Page 12 of 17 · 338 trades